TUCSON, Ariz., Feb. 21, 2013 /PRNewswire/ -- At only 20 years old, Tiernee Gonzalez has been battling two major diseases for most of her young life: heart failure and kidney failure. When she became the first patient at Cincinnati Children's Hospital Medical Center to receive the SynCardia temporary Total Artificial Heart on Nov. 9, her doctors hoped it would bring her one step closer to winning her battle against end-stage heart failure. What they didn't expect, was that it would also help save her one remaining kidney.
"The SynCardia Total Artificial Heart is the only device that lowers CVP to single digits, which creates the potential for liver and kidney recovery," said Dr. David L.S. Morales , chief of pediatric cardiothoracic surgery at Cincinnati Children's. "In the case of this patient, what we initially defined as end-stage renal failure simply became delayed recovery thanks to the total artificial heart."
As a young girl, Gonzalez suffered from a form of kidney cancer called renal cell carcinoma. In addition to having one of her kidneys removed, she had to undergo chemotherapy, which weakened her heart. In August 2006, the summer before she started eighth grade, Gonzalez received a heart transplant.